Electromedical Technologies, Inc 10-Q for FY2021 Q3

Electromedical Technologies, Inc (EMED)

10-Q 2021-11-15 For: 2021-09-30

Added on April 06, 2026

About this 10-Q

Electromedical Technologies, Inc filed this 10-Q on November 15, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).

Headline figures

Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue: $301.16K; up 46.3% from $205.85K a year earlier
Net loss: $3.3M; compared with a net loss of $2.17M a year earlier

Search and read filings like this one from Claude or ChatGPT with the SEC filings MCP server →


16561 N. 92^nd Street, Ste. 101
Scottsdale, AZ	85260
(Address of principal executive offices)	(Zip Code)


Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☒


PART I. FINANCIAL INFORMATION

Item 1.	UNAUDITED FINANCIAL STATEMENTS:	3

	BALANCE SHEETS AS OF SEPTEMBER 30, 2021 AND DECEMBER 31, 2020	3

	STATEMENTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020	4

	STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020	5

	STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020	7

	NOTES TO THE UNAUDITED FINANCIAL STATEMENTS	8

Item 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	23

Item 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	28

Item 4.	CONTROLS AND PROCEDURES	28

PART II. OTHER INFORMATION		29

Item 1.	LEGAL PROCEEDINGS	29

Item 1A.	RISK FACTORS	29

Item 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	29

Item 3.	DEFAULTS UPON SENIOR SECURITIES	40

Item 4.	MINE SAFETY DISCLOSURE	40

Item 5.	OTHER INFORMATION	40

Item 6.	EXHIBITS	42

SIGNATURES		47


	September 30, 2021		December 31, 2020
ASSETS
Current assets:
Cash and cash equivalents	$	164,810	$	264,913
Accounts receivable		30,931		17,694
Inventories		229,906		78,712
Prepaid expenses and other current assets		23,936		285,860
Total current assets		449,583		647,179

Other assets		13,601		20,601
Property and equipment, net		732,813		749,219
Total assets	$	1,195,997	$	1,416,999

LIABILITIES AND STOCKHOLDERS’ DEFICIT

Current liabilities:
Accounts payable	$	244,264	$	262,614
Credit cards payable		14,769		23,710
Accrued expenses and other current liabilities		195,755		201,814
Customer deposits		2,267		28,651
Convertible promissory notes, net of discount of $159,114 and $1,277,255, respectively		813,239		257,398
Related party notes payable		233,500		332,500
PPP loan		—		39,500
Notes payable		—		12,846
Long term debt, current portion		28,516		28,260
Derivative liabilities- convertible promissory notes		803,219		831,852
Total current liabilities		2,335,529		2,019,145

Long-term liabilities:
Bank debt, net of current portion		525,851		546,552
Government debt, net of current portion		155,063		154,302
Other liabilities		10,162		15,603
Total liabilities		3,026,605		2,735,602

Commitments and contingencies (Note 11)		—		—

Stockholders’ deficit
Series A Preferred Stock, 1,000,000 shares authorized and 500,000 outstanding		355,000		355,000
Common stock, $.00001 par value, 125,000,000 shares authorized; 74,926,711 and 27,175,800 shares outstanding at September 30, 2021 and December 31, 2020, respectively		747		269
Additional paid-in-capital		17,828,794		7,957,860
Accumulated deficit		(20,015,149)		(9,631,732)
Total stockholders’ deficit		(1,830,608)		(1,318,603)
Total liabilities and stockholders’ deficit	$	1,195,997	$	1,416,999


	THREE MONTHS ENDED SEPTEMBER 30,				NINE MONTHS ENDED SEPTEMBER 30,
	2021		2020		2021		2020
Net sales	$	301,157	$	205,850	$	670,551	$	557,476

Cost of sales		66,733		57,383		158,065		139,892

Gross profit		234,424		148,467		512,486		417,584

Selling, general and administrative expenses		454,997		2,243,377		2,822,251		3,768,196

Loss from operations		(220,573)		(2,094,910)		(2,309,765)		(3,350,612)

Other income (expense)
Interest expense		(1,105,069)		(52,658)		(2,937,851)		(82,168)
Change in excess fair value of KISS liability- related party		—		—		—		(7,784)
Change in fair market value of derivative liabilities		(1,974,164)		(22,415)		(1,436,756)		(22,415)
Other income (expense)		—				(432)		1,500
Forgiveness of debt		—		—		50,082		—
Total other expense		(3,079,233)		(75,073)		(4,324,957)		(110,867)

Net loss	$	(3,299,806)	$	(2,169,983)	$	(6,634,722)	$	(3,461,479)

Weighted average shares outstanding- basic and diluted		54,356,854		21,875,068		39,670,934		20,201,697
Weighted average loss per share- basic and diluted	$	(0.06)	$	(0.10)	$	(0.17)	$	(0.17)


											Total
	Preferred Stock			Common Stock			Paid in		Accumulated		Stockholders’
	Amount		Shares	Amount		Shares	Capital		Deficit		Deficit
Balance, December 31, 2020	$	355,000	500,000	$	269	27,175,800	$	7,957,860	$	(9,631,732)	$	(1,318,603)

Shares issued for consulting services		—	—		11	1,084,120		693,815		—		693,826

Warrant issued in conjunction with convertible promissory note		—	—		—	—		420,096		—		420,096

Warrants reset in conjunction with convertible promissory notes		—	—		—	—		510,222		(510,222)		—

Conversion of convertible promissory notes		—	—		10	1,019,113		380,093		—		380,103

Stock-based compensation		—	—		11	1,100,000		604,890		—		604,901

Net loss		—	—		—	—		—		(2,560,384)		(2,560,384)

Balance, March 31, 2021	$	355,000	500,000		301	30,379,033	$	10,566,976	$	(12,702,338)	$	(1,780,061)

Warrants reset in conjunction with convertible promissory notes		—	—		—	—		3,230,077		(3,230,077)		—

Conversion of convertible promissory notes		—	—		122	12,161,575		974,192		—		974,314

Shares issued for consulting services		—	—		13	1,250,000		110,387		—		110,400

Net loss		—	—		—	—		—		(774,532)		(774,532)

Balance, June 30, 2021	$	355,000	500,000	$	436	43,790,608	$	14,881,632	$	(16,706,947)	$	(1,469,879)

Warrants reset in conjunction with convertible promissory notes		—	—		—	—		8,396		(8,396)		—

Conversion of convertible promissory notes		—	—		301	30,136,103		2,938,776		—		2,939,077

Shares issued in conjunction with warrant cancellation		—	—		10	1,000,000		(10)		—		—

Net loss		—	—		—	—		—		(3,299,806)		(3,299,806)

Balance, September 30, 2021	$	355,000	500,000	$	747	74,926,711	$	17,828,794	$	(20,015,149)	$	(1,830,608)


	2021		2020
Cash flows from operating activities:
Net loss	$	(6,634,722)	$	(3,461,479)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for allowance for doubtful accounts		3,495		3,765
Stock-based compensation expense		1,409,127		2,761,848
Depreciation and amortization		16,406		16,406
Forgiveness of debt		(49,783)		—
Change in excess fair value of KISS-liability- related party		—		7,784
Amortization of debt discount and day one derivative loss and warrant expense		2,785,844		33,038
Change in fair value of derivative liabilities- convertible promissory notes		1,436,756		22,415
Change in operating assets and liabilities:
Other		2,839		—
Accounts receivable		(16,732)		(4,939)
Inventories		(151,194)		(37,806)
Prepaid expenses and other current assets		261,924		(128,960)
Other assets		7,000		(60,021)
Accounts payable		(11,350)		57,036
Credit cards payable		(8,941)		(8,478)
Accrued expenses and other current liabilities		75,083		(28,401)
Customer deposits		(26,384)		24,660
Other liabilities		(5,441)		7,488
Net cash used in operating activities		(906,073)		(795,644)

Cash flows from financing activities:
Short-term financing		—		(40,308)
Proceeds from PPP loan		—		39,500
Proceeds from government debt		—		155,900
Repayments on bank debt		(19,684)		(12,471)
Related party notes payable-net		(99,000)		24,500
Issuance of convertible promissory notes		937,500		665,000
Repayments on notes payable		(12,846)		(1,000)
Issuance of common stock for cash - net		—		50,000
Net cash provided by financing activities		805,970		881,121

Net (decrease) increase in cash and cash equivalents		(100,103)		85,477

Cash and cash equivalents, beginning of period		264,913		—

Cash and cash equivalents, end of period	$	164,810	$	85,477

Supplemental disclosures of cash flow information:
Cash paid during the period for:
Interest	$	29,625	$	37,408
Income taxes	$	—	$	—

Non-cash investing and financing activities:

Shares issued in conjunction with vendor settlement	$	—	$	7,352
Warrants, common stock and beneficial conversion feature issued in conjunction with convertible promissory notes	$	420,096	$	490,000
Derivative liabilities issued in conjunction with convertible promissory notes	$	1,197,607	$	171,892
Conversion of convertible promissory notes, derivative liabilities and accrued interest into shares of common stock	$	4,290,655	$	—
Conversion of KISS-liability related party to common stock	$	—	$	1,452,545


	Level 1		Level 2		Level 3		Total
Liabilities

Derivative liabilities – convertible promissory notes	$	—	$	—	$	803,219	$	803,219

Total fair value	$	—	$	—	$	803,219	$	803,219


Fair value- December 31, 2020	$	831,852
Change in fair value of derivative liabilities		1,436,756
Derivative liabilities in conjunction with convertible promissory notes		1,197,607
Conversion of convertible promissory notes		(2,662,996)
Fair value- September 30, 2021	$	803,219


	September 30,		December 31,
	2021		2020
Building	$	875,000	$	875,000
Furniture and equipment		24,987		24,987
		899,987		899,987
Less: accumulated depreciation and amortization		(167,174)		(150,768)
	$	732,813	$	749,219


	September 30,		December 31,
Convertible promissory notes	2021		2020
Principal balance	$	972,353	$	1,534,653
Debt discount balance		(159,114)		(1,277,255)
Net Notes balance	$	813,239	$	257,398


	Principal		Debt Discount		Net
Pre 2020	$	50,000	$	—	$	50,000
July 2020		95,000		—		95,000
August 2020		215,000		—		215,000
August 2020		107,500		—		107,500
November 2020		244,853		(36,487)		208,366
December 2020		110,000		(23,558)		86,442
February 2021		150,000		(99,069)		50,931
	$	972,353	$	(159,114)	$	813,239


	Derivative
	Liability -
	Convertible
	Promissory
	Notes
Balance as of December 31, 2020	$	831,852
Conversion of convertible promissory notes		(2,662,996)
Derivative liabilities in conjunction with convertible promissory notes		1,197,607
Change in fair value of derivative liabilities		1,436,756
Balance as of September 30, 2021	$	803,219


Market value of common stock	$	0.1289
Expected volatility		217.3-284.2
Expected term (in years)		.21-.60
Risk-free interest rate		0.18-0.22	%


				Weighted
		Weighted		Average
	Number	Average		Contractual
	of	Exercise		term
	shares	Price		(years)
Options outstanding at December 31, 2020	445,000	$	.71	1.5

Granted	—		—	—

Exercised	—		—	—

Forfeited	—		—	—

Expired	—		—	—

Options outstanding at September 30, 2021	445,000	$	0.71	.75

Exercisable at September 30, 2021	420,000	$	0.71	.75

Options exercisable and expected to vest at September 30, 2021	445,000	$	0.71	.75


Fair Value of Common Share	$	0.225-0.47
Exercise Price	$	0.40
Risk Free Rate		0.41-1.74	%
Expected Life (Yrs.)		4.86-5.0
Volatility		147.4-154.0	%


Date Issued	Exercise Price		Number Outstanding	Expiration Date
December 1, 2018	$	0.71	100,000		December 1, 2023
May 1, 2020	$	0.52	100,000		May 1, 2025
December 1, 2020	$	0.025	8,100,000		December 1, 2023
February 8, 2021	$	0.025	2,500,000		February 8, 2026
			10,800,000


	2021		2020		Change
Marketing	$	8,309	$	66,415	$	(58,106)
Commissions		61,663		40,850		20,813
Payroll related		203,215		141,637		61,578
Consulting and professional fees		125,843		1,941,003		(1,815,159)
Research and development		9,843		7,200		2,643
Other operating expenses		46,124		53,472		(7,348)
	$	454,997	$	2,243,377	$	(1,788,380)


	2021		2020		Change
Marketing	$	82,676	$	84,565	$	(1,889)
Commissions		150,303		129,616		20,687
Payroll related		1,161,132		1,005,969		155,163
Consulting and professional fees		1,150,582		2,405,755		(1,255,173)
Research and development		152,064		11,200		140,864
Other operating expenses		125,494		138,291		(12,797)
	$	2,822,251	$	3,768,196	$	(945,945)

Exhibit No.	Description of Exhibit	Location

3.1	Certificate of Incorporation.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

3.2	Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on January 9, 2020.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

3.3	Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on July 9, 2020 increasing authorized common stock to 50 million shares.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

3.4	Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on November 1, 2019 designating Series A Preferred Shares.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

3.5	Amendment to Certificate of Incorporation filed with the Delaware Secretary of State on August 23, 2017 converting from a limited liability company to a C corporation.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

3.6	Corporate Bylaws.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

4(vi)	Description of Securities	Incorporated by reference to the Company’s Form 8a-12g filed August 5, 2020.

10.1	Employment Contract; Matthew Wolfson Chief Executive Officer, as amended.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.2	Rule 10b5-1 Sales Plan – Wolfson	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.3	Agility Warrant Agreement, December 1, 2018.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.4	Agility Warrant Agreement, May 1, 2020.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.5	E-Business International, Inc. Stock Purchase Agreement, November 29, 2018.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.6	E-Business International, Inc. Stock Purchase Agreement Product Development, November 29, 2018.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.7	Consulting Agreement, Brenda Andrews, July 1, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.8	Consulting Agreement, Blue Ridge Enterprises, July 9, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.9	Consultant Agreement and directors resolution, October 21, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.10	Stock Purchase Agreement Stephanie Campbell, March 25, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.11	Stock Purchase Agreement Petar Gajic, March 25, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.12	Consent Action for Iakovos Tsakalidis Issuance, October 11, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.13	Option Agreement Kishkovskiy, March 11, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.14	Stock Purchase Agreement, Kelly Lauren Myers, March 25, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.15	Consent Action Nikolai Ogorodnikov Issuance October 11, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.16	Options Agreement Alexander Pedenko June 20, 2019	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.17	Consent Action PYP Enterprises July 1, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.18	Consulting Agreement PYP Enterprises, July 1, 2018.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.19	Stock Purchase Agreement Nicholas Rosin, March 25, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.20	KISS Agreement Blue Ridge Enterprises, LLC, July 6, 2018.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.21	Convertible Promissory Note Luis Lu December 11, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.22	Consulting Agreement Robert L. Hymers III, February 11, 2020.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.23	Consulting Agreement Redstone Communications, LLC, February 27, 2020.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.24	Sales Agreement Edgar Villanueva, October 25, 2017.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.25	Consent Action for Iakovos Tsakalidis, October 25, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.26	Consent Action for Nikolai Ogorodnikov, October 25, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.27	Amendment to KISS Agreement, March 22, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.28	Convertible Promissory Note, Ben and Carol Howden, May 2018.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.29	Notice of Conversion - Howden, October 24, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.30	Taubman Subscription Agreement, October 31, 2018.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.31	Consent Action for Gene Taubman, October 31, 2018.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.32	Consulting Agreement, Robert L. Hymers III, February 11, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.33	Amended Consulting Agreement, Robert L. Hymers III, June 28, 2019.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.34	Stock Purchase Agreement dated June 15, 2020 with Pro Active Partners.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.35	Stock Purchase Agreement dated June 4, 2020 with Vista Capital Investments, LLC.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.36	Convertible Promissory Note dated June 4, 2020 with Vista Capital Investments, LLC.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.37	Warrant Issued to Vista Capital Investments, LLC dated June 4, 2020.	Incorporated by reference to the Company’s Form S-1/A-4 filed on July 20, 2020.

10.38	July 21, 2020 Convertible Promissory Note with JRD-HD Enterprises III, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.39	July 21, 2020 Securities Purchase Agreement with JRD-HD Enterprises III, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.40	August 4, 2020 Note Purchase Agreement with JRD-HD Enterprises III, LLC.	Incorporated by reference to the Company’s Form 8a-12g filed August 5, 2020.

10.41	August 4, 2020 8% Convertible Note with JRD-HD Enterprises III, LLC.	Incorporated by reference to the Company’s Form 8a-12g filed August 5, 2020.

10.42	August 11, 2020 10% Convertible Promissory Note with Redstart Holdings Corp.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.43	August 11, 2020 Securities Purchase Agreement with Redstart Holdings Corp.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.44	September 3, 2020 Convertible Promissory Note JR-HD Enterprises, III, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.45	September 3, 2020 Note Purchase Agreement with JR-HD Enterprises, III, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.46	September 8, 2020 10% Convertible Promissory Note with Redstart Holdings Corp.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.47	September 8, 2020 Securities Purchase Agreement with Redstart Holdings Corp.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.48	September 28, 2020 Convertible Promissory Note with JSJ Investments, Inc.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.49	October 22, 2020 Convertible Promissory Note with Redstart Holdings Corp.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.50	November 3, 2020 Securities Purchase Agreement with JR-HD Enterprises, III, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.51	November 3, 2020 Convertible Note with JR-HD Enterprises, III, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.52	December 1, 2020 Convertible Note with Jefferson Street Capital, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.53	December 1, 2020 Securities Purchase Agreement with Jefferson Street Capital, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.54	December 3, 2020 Securities Purchase Agreement with JR-HD Enterprises, III, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.55	December 3, 2020 Convertible Promissory Note with JR-HD Enterprises, III, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.56	December 14, 2020 Securities Purchase Agreement with GS Capital Partners, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.57	December 14, 2020 Convertible Promissory Note with GS Capital Partners, LLC.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

10.58	February 8, 2021 Securities Purchase Agreement, Warrant Agreement, Convertible Debenture and Registration Rights Agreement with YA II PN, Ltd.	Incorporated by reference to the Company’s Form 8-K filed February 12, 2021.

10.59	November 10, 2021 Placement Agent Agreement, Univest Securities.	Filed herewith.

10.60	November 10, 2021 Registration Rights Agreement, White Lion Capital, LLC	Filed herewith.

10.61	November 10, 2021 Common Stock Purchase Agreement, White Lion Capital, LLC	Filed herewith.

20.01	Amended 2017 Employee and Consultant Stock Ownership Plan.	Incorporated by reference to the Company’s Form 10-K filed on March 30, 2021.

31.1	Certification of Chief Executive Officer.	Filed herewith.

31.2	Certification of Chief Financial Officer.	Filed herewith.

32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	Filed herewith.

32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.	Filed herewith.

101.INS	Inline XBRL Instance Document	Filed herewith.

101.SCH	Inline XBRL Taxonomy Extension Schema Document	Filed herewith.

101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document	Filed herewith.

101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document	Filed herewith.

101.LAB	Inline XBRL Taxonomy Extension Labels Linkbase Document	Filed herewith.

101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document	Filed herewith.

104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)	Filed herewith.

	ELECTROMEDICAL TECHNOLOGIES INC.

	By:	/s/ Matthew Wolfson
		Matthew Wolfson
		President & Chief Executive Officer
		(Principal Executive Officer)


	By:	/s/ Matthew Wolfson
		Matthew Wolfson
		Chief Financial Officer
		(Principal Financial and Accounting Officer)

UNIVEST SECURITIES, LLC	375 PARK AVE SUITE 1502	212.343.8888
	NEW YORK, NEW YORK

By:	/s/ Edric Guo

	Name:	Edric Guo
	Title:	Chief Executive Officer


	THE COMPANY:

	ELECTROMEDICAL TECHNOLOGIES, INC.

	By:
	Name:	Matthew Wolfson
	Title:	Chief Executive Officer

	THE INVESTOR:

	WHITE LION CAPITAL, LLC

	By:
	Name:	Sam Yaffa
	Title:	Managing Director


		Very truly yours,
		[Company Counsel]

		By:
cc:	WHITE LION CAPITAL LLC


ELECTROMEDICAL TECHNOLOGIES, INC.


	By:
	Name:	Matthew Wolfson
	Title:	Chief Executive Officer


Date: November 15, 2021	By:	/s/ Matthew Wolfson
		Matthew Wolfson
		Principal Executive Officer